Start the conversation
The reported buyout of Astex Pharmaceuticals Inc. (Nasdaq: ASTX) that we told you about in yesterday's Private Briefing was confirmed - making this the eighth recommendation to result in a buyout or merger since we launched this service just two years ago.
It's also our ninth recommendation to double, triple or quadruple during that same two-year time frame.
As the executive editor of Money Morning, Bill Patalon has access to investing strategies that are powerful and worth a fortune. And triple-digit gains like 101%... 122%... 160%... and 261% are not uncommon. And right now, he's looking at a little company that's poised to soar 201%. The stock is trading for under $10 a share right now but this won't last long. So don't wait. Go here for details.